Background
Neutrophil/lymphocyte percentage is a helpful test for evaluation of systemic
inflammation. This study aimed to investigate neutrophil/lymphocyte percentage
as an evidence of control status in bronchial asthma.
Patients and methods
The study included 45 (20 males and 25 females) patients and 45 apparently
healthy subjects. Full clinical evaluation, complete blood count (CBC) with
differential white blood cell count, Erythrocyte sedimentation rate (ESR),
C-reactive protein (CRP), and total IgE measurement were done for participants.
Results
Neutrophil/lymphocyte percentage and CRP were higher in asthmatics than
controls (statistically significant difference), and they were significantly increased
with uncontrolled asthma. Neutrophil/lymphocyte percentage could predict
uncontrolled asthma with a sensitivity of 66.7%, specificity of 75.6%, positive
predictive value of 73.2%, negative predictive value of 69.4% and accuracy of
71.1%. Neutrophil/lymphocyte percentage increased in asthmatics with asthma
control test (ACT) less than 20 versus patients with ACT of at least 20 (statistically
significant difference), whereas neutrophil/lymphocyte percentage did not differ
significantly among the patients with asthma regarding sex and smoking.
Neutrophil/lymphocyte percentage had direct proportional relation with CRP and
ACT, whereas the relations between neutrophil/lymphocyte percentage and age,
eosinophils, IgE, Forced expiratory volume in first second (FEV1%), duration of the
disease, or number of attacks per year were nonsignificant. No significant
correlation was found between controlled and uncontrolled cases regarding total
leukocyte count (TLC), duration, and onset of the disease. The number of attacks
was significantly higher in uncontrolled cases than controlled ones.
Conclusion
Neutrophil/lymphocyte percentage could predict uncontrolled asthma with high
sensitivity and specificity. Neutrophil/lymphocyte percentage is a rapid, inexpensive
method with routine CBC analysis and could be a useful predictor of asthma control. |